Skip to content
Study aid only. Verify against current guidelines before clinical use.
Step 2 CK · Internal Medicine · Hematology/Oncology

Anemia Workup (Clinical)

Start with the MCV, finish by finding the source

Hematology/Oncology·Anemias & Red Cell Disorders·6 min read·9 high-yield points·Reviewed by Veli Bakalov, MD @HemeOncBuddy
Study materialsNo account needed
Card deckActive-recall cards · quick checks · quiz

The framework: MCV first, then the reticulocyte count

Two numbers frame the workup. Classify every anemia by mean corpuscular volume (MCV): microcytic <80 fL, normocytic 80–100 fL, macrocytic >100 fL. Then check the reticulocyte count, corrected for the degree of anemia: a high count means the marrow is responding to blood loss or hemolysis; a low count means underproduction. A peripheral smear belongs in every workup.

  1. Check the MCVMicro, normo, or macro sends you down three different roads.
  2. Microcytic (<80)Iron deficiency, thalassemia, anemia of chronic disease: iron studies next.
  3. Normocytic (80–100)Check reticulocytes: high = bleeding or hemolysis; low = chronic disease, CKD, marrow failure or infiltration.
  4. Macrocytic (>100)Megaloblastic (B12/folate) vs non-megaloblastic causes.
MCV-based approach to anemia

Correcting the count. A raw percentage overstates output when the hematocrit is low, so multiply it by hematocrit ÷ 45; a reticulocyte production index below 2 signals inadequate production. Low-retic normocytic anemias include anemia of chronic disease, CKD (erythropoietin deficiency), early iron deficiency, and aplastic anemia or marrow infiltration.

Microcytic anemia: iron studies sort TAILS

TAILS. The microcytic differential is Thalassemia, Anemia of chronic disease, Iron deficiency, Lead poisoning, and Sideroblastic anemia. Iron deficiency is the most common cause overall; anemia of chronic disease is usually normocytic but can be microcytic. Iron studies separate them.

Ferritin is the single best test. Iron deficiency shows low ferritin, low serum iron, high TIBC (transferrin is upregulated), and low transferrin saturation, a picture of true depletion. Ferritin is an acute-phase reactant and rises with inflammation, so a normal ferritin in an inflamed patient does not fully exclude iron deficiency.

Anemia of chronic disease accompanies chronic infection, autoimmune disease, and malignancy. Inflammation (IL-6) raises hepcidin, which degrades ferroportin and blocks iron release from macrophages and absorption from the gut: a functional block, not true depletion. Expect low iron, low TIBC, low-normal saturation, and normal-to-high ferritin. Treat the underlying disease.

Iron studies across the microcytic anemias
FeatureIron deficiencyChronic diseaseThalassemia traitSideroblastic
FerritinLowNormal–highNormalHigh
Serum ironLowLowNormalHigh
TIBCHighLowNormalNormal–low
SaturationLowLow–normalNormalHigh
ClueLow RBC count; Mentzer >13Chronic inflammation; hepcidinNormal/high RBC count, target cells; Mentzer <13Ringed sideroblasts on Prussian blue marrow stain
Lead poisoning is an acquired cause of sideroblastic anemia; confirm it with a blood lead level.

Thalassemia trait. Suspect it when the MCV is very low but the RBC count is normal or high, target cells are present, and iron studies are normal. The Mentzer index (MCV ÷ RBC count) is <13 in thalassemia and >13 in iron deficiency. Electrophoresis shows elevated HbA2 in β-thalassemia trait; α-thalassemia trait has a normal adult electrophoresis and is a diagnosis of exclusion or genetic testing. Empiric iron does not help and risks overload.

Lead and other sideroblastic causes. Lead inhibits ferrochelatase and ALA dehydratase, causing basophilic stippling, abdominal pain, wrist or foot drop, and developmental delay in children; remove the exposure and chelate (succimer; EDTA plus dimercaprol when severe). Other causes of ringed sideroblasts include alcohol, isoniazid (vitamin B6 deficiency), copper deficiency, and X-linked ALAS2 mutations; pyridoxine treats many cases.

Iron deficiency: find the source, then replace

A symptom, not a diagnosis. In premenopausal women, menstrual loss and pregnancy are the usual explanations. In men and postmenopausal women, new iron-deficiency anemia is GI blood loss, and a GI malignancy, until proven otherwise: colonoscopy (and upper endoscopy) is mandatory to exclude colorectal cancer. Clues include pica, koilonychia, glossitis, and angular cheilitis; Plummer-Vinson syndrome adds an esophageal web. If endoscopy is unrevealing, test for celiac disease and H. pylori, which impair absorption.

  1. Confirm deficiencyLow ferritin, high TIBC, low saturation.
  2. Find the sourceMenses or pregnancy in premenopausal women; colonoscopy plus EGD in men and postmenopausal women.
  3. Replace orallyFerrous sulfate, every-other-day dosing.
  4. Check the responseReticulocytes rise in about a week; continue several months to refill stores.
  5. Escalate if neededIV iron for intolerance, malabsorption, ongoing losses, CKD, or IBD.
Iron-deficiency anemia: stepwise management

Oral first, IV when it fails. Every-other-day dosing improves absorption and tolerability because each dose transiently raises hepcidin. Expect GI side effects (constipation, nausea, dark stools). A poor response suggests nonadherence, continued bleeding, or malabsorption.

Macrocytic anemia: B12 versus folate

Megaloblastic vs non-megaloblastic. Megaloblastic anemia reflects impaired DNA synthesis from B12 or folate deficiency (or drugs such as methotrexate and hydroxyurea); hypersegmented neutrophils are the tell. Non-megaloblastic macrocytosis lacks them: alcohol, liver disease, hypothyroidism, myelodysplastic syndrome, and brisk reticulocytosis.

Vitamin B12 vs folate deficiency
FeatureVitamin B12Folate
Classic causesPernicious anemia; strict vegan diet; gastrectomy; terminal ileal disease or resection; metforminPoor diet (alcohol use disorder), pregnancy, chronic hemolysis, methotrexate, phenytoin
Body storesYearsMonths
Neurologic diseaseSubacute combined degeneration, neuropathySpared
Methylmalonic acidElevatedNormal
HomocysteineElevatedElevated
Both produce megaloblastic changes with hypersegmented neutrophils; methylmalonic acid is the discriminator.

Pernicious anemia is the classic cause of B12 deficiency: autoimmune destruction of parietal cells removes intrinsic factor. Anti–intrinsic factor antibodies are highly specific, and the atrophic gastritis raises gastric cancer risk. Neurologic deficits can appear before (or without) anemia.

Always give B12 before folate: folate alone corrects the blood count but can let the neurologic damage worsen.

Hemolysis: confirm it, then sort it

The hemolysis panel. Hemolysis raises LDH, indirect (unconjugated) bilirubin, and the reticulocyte count while dropping haptoglobin, which is consumed as it binds free hemoglobin. The direct antiglobulin (Coombs) test then detects antibody-mediated immune hemolysis, and the smear identifies the mechanism.

Intravascular vs extravascular hemolysis
FeatureIntravascularExtravascular
SiteWithin the circulationSplenic and hepatic macrophages
Distinctive findingsVery low haptoglobin, hemoglobinuria, hemosiderinuriaSplenomegaly, jaundice, spherocytes
ExamplesPNH, microangiopathic hemolytic anemia, transfusion reactionWarm AIHA, hereditary spherocytosis
  • Warm AIHA (IgG, Coombs positive): SLE, CLL, methyldopa, penicillins. Corticosteroids first; rituximab or splenectomy only for refractory disease.
  • Cold agglutinin disease (IgM): Mycoplasma pneumoniae, EBV mononucleosis; acral cyanosis with cold exposure. Avoid cold; steroids work poorly.
  • Coombs negative: G6PD deficiency (bite cells, Heinz bodies after oxidant stress such as sulfa drugs, primaquine, or fava beans), hereditary spherocytosis, sickle cell disease, and microangiopathy with schistocytes (TTP, HUS, DIC, mechanical valves).

Spherocytes appear in both hereditary spherocytosis and warm AIHA; the DAT separates them. G6PD activity can read falsely normal during an acute episode, so repeat it after recovery.

Transfusion and treatment principles

<7 g/dLrestrictive threshold for most stable inpatients
<8 g/dLthreshold with active cardiac disease or symptoms
~1 g/dLhemoglobin rise per unit of packed red cells

Treat the cause, not the number. Active hemorrhage and instability are transfused on clinical grounds. Chronic anemia is corrected by treating its cause (iron, B12, or folate; control of inflammation; erythropoiesis-stimulating agents in CKD once iron is replete) rather than by reflexive transfusion.